.
MergerLinks Header Logo

New Deal


Announced

Completed

P3 Health Partners went public via a SPAC merger with Foresight Acquisition in a $2.3bn deal.

Financials

Edit Data
Transaction Value£1,624m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Synopsis

Edit

P3 Health Partners, a health population management group, went public via a SPAC merger with Foresight Acquisition, a special purposes company, in a $2.3bn deal. Investors in PIPE included Fidelity Management & Research and Janus Henderson. “Today marks an important milestone in our mission to transform healthcare for patients, providers, and payors through value-based care. We have the right team and delivery model to help physicians and payors accelerate the move to value-based care within a growing market for Medicare beneficiaries. As a public company, we will continue to provide a differentiated approach to patient care for all key stakeholders while delivering proven care outcomes and enhancing patient and provider satisfaction," Sherif Abdou, P3 CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US